Cargando…

AEBP1 is a Novel Oncogene: Mechanisms of Action and Signaling Pathways

Adipocyte enhancer-binding protein 1 (AEBP1) is a transcriptional repressor involved in the regulation of critical biological processes including adipogenesis, mammary gland development, inflammation, macrophage cholesterol homeostasis, and atherogenesis. Several years ago, we first reported the abi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majdalawieh, Amin F., Massri, Mariam, Ro, Hyo-Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273425/ https://www.ncbi.nlm.nih.gov/pubmed/32565808 http://dx.doi.org/10.1155/2020/8097872

Ejemplares similares

Regulation of IκBα Function and NF-κB Signaling: AEBP1 Is a Novel Proinflammatory Mediator in Macrophages
por: Majdalawieh, Amin, et al.
Publicado: (2010)

PPARγ1 and LXRα face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1
por: Majdalawieh, Amin, et al.
Publicado: (2010)

Lactation Defect with Impaired Secretory Activation in AEBP1-Null Mice
por: Zhang, Lei, et al.
Publicado: (2011)

Correction: Lactation Defect with Impaired Secretory Activation in AEBP1-Null Mice
por: Zhang, Lei, et al.
Publicado: (2011)

Case report: Two individuals with AEBP1-related classical-like EDS: Further clinical characterisation and description of novel AEBP1 variants
por: Angwin, Chloe, et al.
Publicado: (2023)

Molecular Characterization of AEBP1 at Transcriptional Level in Glioma
por: Wang, Kuanyu, et al.
Publicado: (2021)

Retrotransposon-Derived Promoter of Mammalian Aebp2
por: Kim, Hana, et al.
Publicado: (2015)

AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-κB Pathway
por: Guo, Kai, et al.
Publicado: (2020)

Aebp2 as an Epigenetic Regulator for Neural Crest Cells
por: Kim, Hana, et al.
Publicado: (2011)

Hypolipidemic and Anti-Atherogenic Effects of Sesamol and Possible Mechanisms of Action: A Comprehensive Review
por: Majdalawieh, Amin F., et al.
Publicado: (2023)

AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells
por: Sinha, Swati, et al.
Publicado: (2019)

AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma
por: Li, Dandan, et al.
Publicado: (2021)

Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
por: Zhou, Qianwen, et al.
Publicado: (2022)

Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease
por: Tao, Yiying, et al.
Publicado: (2021)

AEBP1 Promotes the Occurrence and Development of Abdominal Aortic Aneurysm by Modulating Inflammation via the NF-κB Pathway
por: Ren, Jiancong, et al.
Publicado: (2020)

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma
por: Hu, W, et al.
Publicado: (2013)

AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses
por: Liu, Mingjian, et al.
Publicado: (2021)

AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2
por: Kim, Hana, et al.
Publicado: (2009)

Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome
por: Ritelli, Marco, et al.
Publicado: (2019)

AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
por: Liu, Jun-yan, et al.
Publicado: (2018)

Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling
por: Hou, Yanli, et al.
Publicado: (2021)

AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p
por: Gerhard, Glenn S., et al.
Publicado: (2019)

Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells
por: Sauer, Thorben, et al.
Publicado: (2022)

Structural and biochemical insights into human zinc finger protein AEBP2 reveals interactions with RBBP4
por: Sun, Aiai, et al.
Publicado: (2017)

Health benefits of sesamin on cardiovascular disease and its associated risk factors
por: Dalibalta, Sarah, et al.
Publicado: (2020)

Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive
por: Majdalawieh, Amin F., et al.
Publicado: (2016)

Overview of Antagonists Used for Determining the Mechanisms of Action Employed by Potential Vasodilators with Their Suggested Signaling Pathways
por: Loh, Yean Chun, et al.
Publicado: (2016)

The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity
por: Chekmarev, Jason, et al.
Publicado: (2021)

Functional analysis of AEBP2, a PRC2 Polycomb protein, reveals a Trithorax phenotype in embryonic development and in ESCs
por: Grijzenhout, Anne, et al.
Publicado: (2016)

Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
por: Sharma, Anmol, et al.
Publicado: (2021)

Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
por: Nolan, Aoife A., et al.
Publicado: (2021)

Congenital Defects in a Patient Carrying a Novel Homozygous AEBP1 Variant: Further Expansion of the Phenotypic Spectrum of Ehlers–Danlos Syndrome Classical-like Type 2?
por: Di Giosaffatte, Niccolò, et al.
Publicado: (2022)

Interaction of viral oncogenic proteins with the Wnt signaling pathway
por: Khanizadeh, Sayyad, et al.
Publicado: (2018)

Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
por: Chen, Jiezhong, et al.
Publicado: (2019)

Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks
por: Sharma, Monica, et al.
Publicado: (2020)

Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms
por: Isacescu, Ecaterina, et al.
Publicado: (2023)

CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors
por: Dcona, M. Michael, et al.
Publicado: (2017)

Molecular switches in signaling networks as a mechanism of action for oncogenic mutations in proximity of tyrosine residues
por: Emdal, Kristina B., et al.
Publicado: (2019)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

Notch signalling pathway as an oncogenic factor involved in cancer development
por: Brzozowa-Zasada, Marlena, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_al2e4m0n4jq89o1eq27jaovitt